Metabolism of Glycosphingolipids and targeting GM2 synthesis pathway to develop substrate reduction approach in Tay-Sachs and Sandhoff disorders. [PDF]
GM2 gangliosidosis is a rare genetic lysosomal storage disorder (LSD) in children, with no effective therapies available presently. Tay-Sachs (TSD) and Sandhoff disorders (SD) are caused by a disruption of the catabolic pathway of gangliosides in ...
Abidi, Iram
core
Late-onset GM2 gangliosidosis: magnetic resonance imaging, diffusion tensor imaging, and correlational fiber tractography differentiate Tay-Sachs and Sandhoff diseases. [PDF]
Lewis CJ +5 more
europepmc +1 more source
A multiplexed targeted method for profiling of serum gangliosides and glycosphingolipids: application to GM2-gangliosidosis. [PDF]
Kim J +5 more
europepmc +1 more source
4-Phenylbutyric acid mitigates ER stress-induced neurodegeneration in the spinal cords of a GM2 gangliosidosis mouse model. [PDF]
Weaver FE +5 more
europepmc +1 more source
GM2 Gangliosidosis in Shiba Inu Dogs with an In-Frame Deletion in HEXB. [PDF]
Kolicheski A +10 more
europepmc +1 more source
Infantile Monosialoganglioside2 (GM2) Gangliosidosis With Concurrent Bronchopneumonia: An Extraordinary Case of Tay-Sachs Disease. [PDF]
Grezenko H +5 more
europepmc +1 more source
Canine GM2-Gangliosidosis Sandhoff Disease Associated with a 3-Base Pair Deletion in the HEXB Gene. [PDF]
Wang P +5 more
europepmc +1 more source
GM2 gangliosidosis AB variant: novel mutation from India - a case report with a review. [PDF]
Sheth J +5 more
europepmc +1 more source
GM2-Gangliosidosis, AB Variant: Clinical, Ophthalmological, MRI, and Molecular Findings. [PDF]
Renaud D, Brodsky M.
europepmc +1 more source
Similarities and differences in the late-onset GM2 gangliosidoses: Tay-Sachs and Sandhoff diseases. [PDF]
Lewis CJ +16 more
europepmc +1 more source

